Robin Scott Gray
Examiner (ID: 11474)
Most Active Art Unit | 1307 |
Art Unit(s) | 1307, 1773, 1732 |
Total Applications | 176 |
Issued Applications | 83 |
Pending Applications | 18 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18902791
[patent_doc_number] => 20240018276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => ZWITTERIONICALLY MODIFIED POLYMERS AND HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 18/122416
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122416 | ZWITTERIONICALLY MODIFIED POLYMERS AND HYDROGELS | Mar 15, 2023 | Pending |
Array
(
[id] => 18672868
[patent_doc_number] => 20230310314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/175442
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175442
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175442 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | Feb 26, 2023 | Pending |
Array
(
[id] => 18467072
[patent_doc_number] => 20230201352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Compositions for Enhancing Bioavailability of Pharmaceuticals, Supplements and Ingested Substances
[patent_app_type] => utility
[patent_app_number] => 18/175020
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175020 | Compositions for Enhancing Bioavailability of Pharmaceuticals, Supplements and Ingested Substances | Feb 26, 2023 | Pending |
Array
(
[id] => 19310397
[patent_doc_number] => 12036191
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-16
[patent_title] => Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
[patent_app_type] => utility
[patent_app_number] => 18/169571
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7711
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169571 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | Feb 14, 2023 | Issued |
Array
(
[id] => 18842514
[patent_doc_number] => 20230404918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/109421
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109421 | FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE | Feb 13, 2023 | Pending |
Array
(
[id] => 18800078
[patent_doc_number] => 11833224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-05
[patent_title] => Lyoprotectant compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/166416
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 8286
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166416 | Lyoprotectant compositions and uses thereof | Feb 7, 2023 | Issued |
Array
(
[id] => 18656055
[patent_doc_number] => 20230301921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => Encased Tamper Resistant Controlled Release Dosage Forms
[patent_app_type] => utility
[patent_app_number] => 18/096686
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096686 | Encased tamper resistant controlled release dosage forms | Jan 12, 2023 | Issued |
Array
(
[id] => 18610812
[patent_doc_number] => 20230277542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
[patent_app_type] => utility
[patent_app_number] => 18/153528
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153528 | Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile | Jan 11, 2023 | Pending |
Array
(
[id] => 18418362
[patent_doc_number] => 20230172820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Compositions Containing Microcapsules
[patent_app_type] => utility
[patent_app_number] => 18/150292
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150292 | Compositions Containing Microcapsules | Jan 4, 2023 | Pending |
Array
(
[id] => 18495993
[patent_doc_number] => 20230218518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING EOSINOPHILIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/150152
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150152 | COMPOSITIONS AND METHODS FOR TREATING EOSINOPHILIC DISORDERS | Jan 3, 2023 | |
Array
(
[id] => 18346991
[patent_doc_number] => 20230135101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/146022
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146022 | BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE | Dec 22, 2022 | Pending |
Array
(
[id] => 18339135
[patent_doc_number] => 20230131084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PULLULAN CAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/145463
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145463 | Pullulan capsules | Dec 21, 2022 | Issued |
Array
(
[id] => 18296819
[patent_doc_number] => 20230106505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => IONTOPHORETIC MICRONEEDLE DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/063085
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063085
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063085 | IONTOPHORETIC MICRONEEDLE DEVICE | Dec 7, 2022 | Pending |
Array
(
[id] => 18869847
[patent_doc_number] => 11857627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
[patent_app_type] => utility
[patent_app_number] => 17/994166
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/994166 | Fractionated radiotherapy and chemotherapy with an oxygen therapeutic | Nov 24, 2022 | Issued |
Array
(
[id] => 18324783
[patent_doc_number] => 20230122911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => FORMULATIONS OF ENZALUTAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/985220
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985220 | FORMULATIONS OF ENZALUTAMIDE | Nov 10, 2022 | Pending |
Array
(
[id] => 18199739
[patent_doc_number] => 20230053259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/979822
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979822 | Deodorant compositions | Nov 2, 2022 | Issued |
Array
(
[id] => 18610696
[patent_doc_number] => 20230277426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TOPICAL SKIN COMPOSITIONS FOR TREATING WRINKLES
[patent_app_type] => utility
[patent_app_number] => 17/965483
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965483 | Topical skin compositions for treating wrinkles | Oct 12, 2022 | Issued |
Array
(
[id] => 18319512
[patent_doc_number] => 20230117640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => PUTRESCINE TOPICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/046221
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046221 | PUTRESCINE TOPICAL FORMULATIONS | Oct 12, 2022 | Abandoned |
Array
(
[id] => 18180616
[patent_doc_number] => 20230041345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ANTIPERSPIRANT AND DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/961089
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961089 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | Oct 5, 2022 | Pending |
Array
(
[id] => 18412011
[patent_doc_number] => 11666538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/959681
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19864
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959681 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Oct 3, 2022 | Issued |